Have a personal or library account? Click to login
Length of hospital stay and survival of hospitalized COVID-19 patients during the second wave of the pandemic: A single centre retrospective study from Slovenia Cover

Length of hospital stay and survival of hospitalized COVID-19 patients during the second wave of the pandemic: A single centre retrospective study from Slovenia

Open Access
|Sep 2022

References

  1. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323:1545-6. doi: 10.1001/jama.2020.4031.
  2. Arabi YM, Murthy S, Webb S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020;46:833-6. doi: 10.1007/s00134-020-05955-1.
  3. Moghadas SM, Shoukat A, Fitzpatrick MC, Wells CR, Sah P, Pandey A, et al. Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proc Natl Acad Sci USA. 2020;117:9122-6. doi: 10.1073/pnas.2004064117.
  4. IHME COVID-19 health service utilization forecasting tim. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months. MedRxiv. 2020. doi: 10.1101/2020.03.27.20043752.
  5. Halpern NA, Goldman DA, Tan KS, Pastores SM. Trends in critical care beds and use among population groups and Medicare and Medicaid beneficiaries in the United States: 2000–2010. Crit Care Med. 2016;44:1490-9. doi: 10.1097/CCM.0000000000001722.
  6. Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CA, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18:270. doi: 10.1186/s12916-020-01726-3.
  7. Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi: 10.1136/bmj.m1328.
  8. Manevski D, Pohar Perme M. Estimation of the reproductive number and the outbreak size of SARS-CoV-2 in Slovenia. Zdrav Vestn. 2020;89:591-602. doi: 10.6016/ZdravVestn.3068.
  9. Ružić Gorenjec N, Kejžar N, Manevski D, Pohar Perme M, Vratanar B, Blagus R. COVID-19 in Slovenia, from a success story to disaster: what lessons can be learned?. Life, 2021;11(10):1045. doi: 10.3390/life11101045
  10. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. doi: 10.1016/S0140-6736(20)30566-3.
  11. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382;1787-99. doi: 10.1056/NEJMoa2001282.
  12. Therneau TM, Lumley T. Package ‘survival’. R Top Doc. 2015;128:28-33.
  13. de Wreede LC, Fiocco M, Putter H. The mstate: an R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011;38:1-30. doi: 10.18637/jss.v038.i07
  14. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. Accessed January 25th, 2022 at:: https://www.R-project.org/
  15. Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, et al. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS One. 2021;16:e0249038. doi: 10.1371/journal.pone.0249038.
  16. Guillon A, Laurent E, Godillon L, Kimmoun A, Grammatico-Guillon L. In-hospital mortality rates of critically ill COVID-19 patients in France: a nationwide cross-sectional study of 45,409 ICU patients. Br J Anaesth. 2021;127:e180-2. doi: 10.1016/j.bja.2021.08.006.
  17. Mishra V, Burma AD, Das SK, Parivallal MB, Amudhan S, Rao GN. COVID-19-hospitalized patients in Karnataka: survival and stay characteristics. Indian J Public Health. 2020;64:S221-4. doi: 10.4103/ijph.IJPH_486_20.
  18. Vekaria B, Overton C, Wiśniowski A, Ahmad S, Aparicio-Castro A, Curran-Sebastian J, et al. Hospital length of stay for COVID-19 patients: data-driven methods for forward planning. BMC Infect Dis. 2021;21:700. doi: 10.1186/s12879-021-06371-6.
  19. Jamshidi B, Jamshidi Zargaran S, Bekrizadeh H, Rezaei M, Najafi F. Comparing length of hospital stay during COVID-19 pandemic in the USA, Italy and Germany. Int J Qual Health Care. 2021;33:mzab050. doi: 10.1093/intqhc/mzab050.
  20. Rodriguez-Gonzalez CG, Chamorro-de-Vega E, Valerio M, Amor-Garcia MA, Tejerina F, Sancho-Gonzalez M, et al. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid. Int J Antimicrob Agents. 2021;57:106249. doi: 10.1016/j.ijantimicag.2020.106249.
  21. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763-70. doi: 10.1016/S0140-6736(20)31189-2.
  22. Lewnard JA, Liu VX, Jackson ML, Schmidt MA, Jewell BL, Flores JP, et al. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. 2020;369:m1923. doi: 10.1136/bmj.m1923.
  23. Zangrillo A, Beretta L, Silvani P, Colombo S, Scandroglio AM, Dell’Acqua A, et al. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency. Crit Care Resusc. 2020;22:91-4. doi: 10.3316/informit.196484700544171.
  24. Phua J, Weng L, Ling L, Egi M, Lim C-M, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506-17. doi: 10.1016/S2213-2600(20)30161-2.
  25. Armstrong R, Kane A, Cook T. Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies. Anaesthesia. 2020;75:1340-9. doi: 10.1111/anae.15201.
  26. Kung S, Doppen M, Black M, Braithwaite I, Kearns C, Weatherall M, et al. Underestimation of COVID-19 mortality during the pandemic. ERJ Open Res. 2021;7:00766-2020. doi: 10.1183/23120541.00766-2020.
  27. Macedo A, Gonçalves N, Febra C. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol. 2021;57:14-21. doi: 10.1016/j.annepidem.2021.02.012.
  28. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. Jama. 2020;323:1574-81. doi: 10.1001/jama.2020.5394.
  29. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323:1061-9. doi: 10.1001/jama.2020.1585.
  30. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5.
  31. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81. doi: 10.1016/S2213-2600(20)30079-5.
  32. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama. 2020;323:1612-4. doi: 10.1001/jama.2020.4326.
  33. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. doi: 10.1016/S0140-6736(20)30566-3.
  34. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382:2012-22. doi: 10.1056/NEJMoa2004500.
  35. Gray WK, Navaratnam AV, Day J, Babu P, Mackinnon S, Adelaja I, et al. Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: a national observational study for the Getting It Right First Time Programme. EClin Med. 2021;35:100859. doi: 10.1016/j.eclinm.2021.100859.
  36. Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, Lozano-Cruz OA, Ortiz-Brizuela E, Tovar-Méndez VH, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City: causes of death, risk factors and the impact of hospital saturation. PLoS One. 2021;16:e0245772. doi: 10.1371/journal.pone.0245772.
  37. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama. 2020;323:2052-9. doi: 10.1001/jama.2020.6775.
  38. Ñamendys-Silva SA, Gutiérrez-Villaseñor A, Romero-González JP. Hospital mortality in mechanically ventilated COVID-19 patients in Mexico. Intensive Care Med. 2020;46:2086-8. doi: 10.1007/s00134-020-06256-3.
  39. ICNARC report on COVID-19 in critical care: 24 April 2020. Accessed January 25th, 2022 at: https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports
  40. Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853-62. doi: 10.1016/S2213-2600(20)30316-7.
  41. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID‐19 patients: a systematic review and meta‐analysis. J Med Virol. 2020;92:1875-83. doi: 10.1002/jmv.26050
  42. Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201:1430-4. doi: 10.1164/rccm.202003-0736LE.
  43. Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension. 2020;76:366-72. doi: 10.1161/HYPERTENSIONAHA.120.15324.
  44. Romero Starke K, Petereit-Haack G, Schubert M, Kämpf D, Schliebner A, Hegewald J, et al. The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression. Int J Environ Res Public Health. 2020;17:5974. doi: 10.3390/ijerph17165974.
  45. Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:6317. doi: 10.1038/s41467-020-19741-6.
  46. Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. Plos One. 2021;16:e0254066. doi: 10.1371/journal.pone.0254066.
  47. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8:e35.
  48. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. doi: 10.1016/j.ijid.2020.03.017.
  49. Roth GA, Emmons-Bell S, Alger HM, Bradley SM, Das SR, De Lemos JA, et al. Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic. JAMA Netw Open. 2021;4:e218828. doi: 10.1001/jamanetworkopen.2021.8828.
  50. Velikonja NK, Erjavec K, Verdenik I, Hussein M, Velikonja VG. Association between preventive behaviour and anxiety at the start of the COVID-19 pandemic in Slovenia. Zdr Varst. 2020;60:17-24. doi: 10.2478/sjph-2021-0004.
  51. Jordan T, Siuka D, Kozjek Rotovnik M, Pfeifer M. COVID-19 and vitamin D - a systematic review. Zdr Varst. 2022;61:124-32. doi: 10.2478/sjph-2022-0017.
DOI: https://doi.org/10.2478/sjph-2022-0027 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 201 - 208
Submitted on: Jan 30, 2022
|
Accepted on: Jul 28, 2022
|
Published on: Sep 28, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Aleš Rozman, Boštjan Rituper, Mark Kačar, Peter Kopač, Mihaela Zidarn, Maja Pohar Perme, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.